MCDERMOTT+ LLC for LYMPHEDEMA ADVOCACY GROUP
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to Medicares coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 133 - Consolidated Appropriations Act, 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE WALDO | — |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
| EMMA ZIMMERMAN | — |
Medicare/Medicaid MMM
Issues relating to Medicares coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 133 - Consolidated Appropriations Act, 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE WALDO | — |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
| EMMA ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.